Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stephan Roever is active.

Publication


Featured researches published by Stephan Roever.


Proceedings of the National Academy of Sciences of the United States of America | 2000

A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: Anxiolytic profile in the rat

François Jenck; Juergen Wichmann; Frank M. Dautzenberg; Jean-Luc Moreau; Abdel M. Ouagazzal; James R. Martin; Kenneth Lundstrom; Andrea Cesura; Sonia Maria Poli; Stephan Roever; Sabine Kolczewski; Geo Adam; Gavin J. Kilpatrick


Archive | 2001

Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands

Jonathan Mark Bentley; Michael John Oakdene Court Bickerdike; Paul Hebeisen; Guy Anthony Oakdene Court Kennett; Sean Lightowler; Patrizio Mattei; Jacques Mizrahi; Timothy James Morley; Jean-Marc Plancher; Hans Richter; Stephan Roever; Sven Taylor; Steven Paul Vickers


Archive | 2006

Pyridine-3-carboxamide derivatives as cb1 inverse agonists

Paul Hebeisen; Hans Iding; Matthias Nettekoven; Ulrike Obst; Stephan Roever; Beat Wirz


Archive | 2007

3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as hdl-cholesterol raising agents

Mirjana Andjelkovic; Agnès Bénardeau; Evelyne Chaput; Paul Hebeisen; Matthias Nettekoven; Sander Ulrike Obst; Constantinos G. Panousis; Stephan Roever


Bioorganic & Medicinal Chemistry Letters | 2006

Synthesis and biological evaluation of novel hexahydro-pyrido[3',2':4,5]pyrrolo[1,2 -a]pyrazines as potent and selective 5-HT2C receptor agonists

Hans Richter; David R. Adams; Agnès Bénardeau; Mike J. Bickerdike; Jonathan Mark Bentley; Toby Jonathan Blench; Ian A. Cliffe; C. Dourish; Paul Hebeisen; Guy Anthony Oakdene Cour Winnersh Kennett; Antony R. Knight; C.S. Malcolm; Patrizio Mattei; A. Misra; Jacques Mizrahi; Nathaniel Julius Monck; Jean-Marc Plancher; Stephan Roever; Jonathan Richard Anthon Roffey; Sven Taylor; Steven Paul Vickers


Archive | 2003

Novel CB 1 receptor inverse agonists

Alexander V. Mayweg; Hans Peter Marty; Werner Mueller; Robert Narquizian; Werner Neidhart; Philippe Pflieger; Stephan Roever


Archive | 2001

1,3,8-TRIAZA-SPIRO'4,5eDECAN-4-ONE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS

Guido Galley; Thierry Godel; Annick Goergler; Torsten Hoffmann; Sabine Kolczewski; Stephan Roever


Archive | 2007

Pyrazine-2-carboxamide derivatives

Michel Dietz; Sabine Gruener; Paul Hebeisen; Sylvie C. Meyer Reigner; Matthias Nettekoven; Bernd Puellmann; Stephan Roever; Christoph Ullmer


Archive | 2004

5ht2c receptor agonists for the treatment of diabetes and obesity

Toby Jonathan Blench; Paul Hebeisen; Hans Richter; Stephan Roever


Archive | 2006

Morpholines as 5ht2c agonists

Jonathan Mark Bentley; Claire Elizabeth Dawson; Wolfgang Guba; Paul Hebeisen; Nathaniel Julius Monck; Robert Mark Pratt; Hans Richter; Stephan Roever; Vicki Ruston

Collaboration


Dive into the Stephan Roever's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge